Arthritis Research-2000 June

Arthritis Research-2000 June

In 2000, The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis BACKGROUND: The therapeutic potential of cannabidiol (CBD), the major nonpsychoactive component of cannabis, was explored in murine collagen-induced arthritis (CIA). CBD treatment commenced at the first clinical signs of arthritis You can read the full article here => http://www.pnas.org/content/97/17/9561.full

Arthritis Research-2010 Aug

In 2010, Cannabinoids as novel anti-inflammatory drugs BACKGROUND: This review will focus on the potential use of cannabinoids as a new class of anti-inflammatory agents against a number of inflammatory and autoimmune diseases that are primarily triggered by activated T cells or other cellular immune components. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/